These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 15916630

  • 21. Corticotropin-releasing factor receptors CRF1 and CRF2 exert both additive and opposing influences on defensive startle behavior.
    Risbrough VB, Hauger RL, Roberts AL, Vale WW, Geyer MA.
    J Neurosci; 2004 Jul 21; 24(29):6545-52. PubMed ID: 15269266
    [Abstract] [Full Text] [Related]

  • 22. Corticotropin-releasing factor modulates maternal separation-induced ultrasonic vocalization in rat pups via activation of CRF1 receptor.
    Ise S, Nagano N, Okuda S, Ohta H.
    Brain Res; 2008 Oct 09; 1234():59-65. PubMed ID: 18703034
    [Abstract] [Full Text] [Related]

  • 23. Pro- and anti-nociceptive effects of corticotropin-releasing factor (CRF) in central amygdala neurons are mediated through different receptors.
    Ji G, Neugebauer V.
    J Neurophysiol; 2008 Mar 09; 99(3):1201-12. PubMed ID: 18171711
    [Abstract] [Full Text] [Related]

  • 24. CRF1 and CRF2 receptors in the bed nucleus of the stria terminalis modulate the cardiovascular responses to acute restraint stress in rats.
    Oliveira LA, Almeida J, Benini R, Crestani CC.
    Pharmacol Res; 2015 Mar 09; 95-96():53-62. PubMed ID: 25829333
    [Abstract] [Full Text] [Related]

  • 25. Lipopolysaccharide induces visceral hypersensitivity: role of interleukin-1, interleukin-6, and peripheral corticotropin-releasing factor in rats.
    Nozu T, Miyagishi S, Nozu R, Takakusaki K, Okumura T.
    J Gastroenterol; 2017 Jan 09; 52(1):72-80. PubMed ID: 27075754
    [Abstract] [Full Text] [Related]

  • 26. The effects of CRF and the urocortins on [3H]GABA release from the rat amygdala--an in vitro superfusion study.
    Bagosi Z, Jászberényi M, Szabó G, Telegdy G.
    Brain Res Bull; 2008 Jan 31; 75(1):15-7. PubMed ID: 18158090
    [Abstract] [Full Text] [Related]

  • 27. Peptide ligand binding properties of the corticotropin-releasing factor (CRF) type 2 receptor: pharmacology of endogenously expressed receptors, G-protein-coupling sensitivity and determinants of CRF2 receptor selectivity.
    Hoare SR, Sullivan SK, Fan J, Khongsaly K, Grigoriadis DE.
    Peptides; 2005 Mar 31; 26(3):457-70. PubMed ID: 15652653
    [Abstract] [Full Text] [Related]

  • 28. Distribution and expression of CRF receptor 1 and 2 mRNAs in the CRF over-expressing mouse brain.
    Korosi A, Veening JG, Kozicz T, Henckens M, Dederen J, Groenink L, van der Gugten J, Olivier B, Roubos EW.
    Brain Res; 2006 Feb 09; 1072(1):46-54. PubMed ID: 16423327
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Effects of dorsal periaqueductal gray CRF1- and CRF2-receptor stimulation in animal models of panic.
    Sergio Tde O, Spiacci A, Zangrossi H.
    Psychoneuroendocrinology; 2014 Nov 09; 49():321-30. PubMed ID: 25146701
    [Abstract] [Full Text] [Related]

  • 31. [Effect of corticotropin releasing factor(CRF) on somatic pain sensitivity in conscious rats: involvement of CRF1 and CRF2 receptors].
    Iarushkina NI, Bagaeva TR, Filaretova LP.
    Ross Fiziol Zh Im I M Sechenova; 2014 Nov 09; 100(11):1287-96. PubMed ID: 25665407
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. A balance theory of peripheral corticotropin-releasing factor receptor type 1 and type 2 signaling to induce colonic contractions and visceral hyperalgesia in rats.
    Nozu T, Takakusaki K, Okumura T.
    Endocrinology; 2014 Dec 09; 155(12):4655-64. PubMed ID: 25279793
    [Abstract] [Full Text] [Related]

  • 34. The behavioural and electrophysiological effects of CRF in rat frontal cortex.
    Zieba B, Grzegorzewska M, Brański P, Domin H, Wierońska JM, Hess G, Smiałowska M.
    Neuropeptides; 2008 Dec 09; 42(5-6):513-23. PubMed ID: 18617263
    [Abstract] [Full Text] [Related]

  • 35. Autoradiographic and in situ hybridization localization of corticotropin-releasing factor 1 and 2 receptors in nonhuman primate brain.
    Sánchez MM, Young LJ, Plotsky PM, Insel TR.
    J Comp Neurol; 1999 Jun 07; 408(3):365-77. PubMed ID: 10340512
    [Abstract] [Full Text] [Related]

  • 36. Role of corticotropin-releasing factor (CRF) receptors in the anorexic syndrome induced by CRF.
    Pelleymounter MA, Joppa M, Carmouche M, Cullen MJ, Brown B, Murphy B, Grigoriadis DE, Ling N, Foster AC.
    J Pharmacol Exp Ther; 2000 Jun 07; 293(3):799-806. PubMed ID: 10869378
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Corticotropin releasing factor enhances attentional function as assessed by the five-choice serial reaction time task in rats.
    Ohmura Y, Yamaguchi T, Futami Y, Togashi H, Izumi T, Matsumoto M, Yoshida T, Yoshioka M.
    Behav Brain Res; 2009 Mar 17; 198(2):429-33. PubMed ID: 19084036
    [Abstract] [Full Text] [Related]

  • 39. Effects of CP 154,526, a CRF1 receptor antagonist, on behavioral responses to cocaine in rats.
    Przegaliński E, Filip M, Frankowska M, Zaniewska M, Papla I.
    Neuropeptides; 2005 Oct 17; 39(5):525-33. PubMed ID: 16139885
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.